BELLEVUE, WA / ACCESS Newswire / July 31, 2026 / OSR Health, Inc. (NASDAQ:OSRH) (&#34;OSR Health&#34; or the &#34;Company&#34;) today announced that the Nasdaq Stock Market (&#34;Nasdaq&#34;) stated in a verbal

<p><strong id="dateline">BELLEVUE, WA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / July 31, 2026 / </strong>OSR Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/OSRH">OSRH</a>) ("OSR Health" or the "Company") today announced that the Nasdaq Stock Market ("Nasdaq") stated in a verbal communication with the Company that the Company's Shareholder Loyalty Contingent Value Rights (CVR) program will not result in any mechanical adjustment to the price of OSR Health's common stock - either upon the distribution of the CVRs or upon the delivery of additional shares of common stock to enrolled holders under the program.</p><p><strong>What this means for shareholders:</strong></p><ul style="list-style-type:disc;"><li><p><strong>No mechanical price adjustment.</strong> Nasdaq will not apply an ex-date or other downward adjustment to the OSRH share price in connection with the CVR distribution or the delivery of additional shares.</p></li><li><p><strong>Purely additive.</strong> Enrolled holders receive additional shares at no cost as the program's price milestones are met.</p></li><li><p><strong>Market-determined value.</strong> The value of OSRH shares will be set by the market - not adjusted by the exchange.</p></li><li><p><strong>Record date: August 14, 2026.</strong> Hold your shares by this date to be eligible.</p></li></ul><p>"This communication with Nasdaq provides clarity on an important structural question about our CVR Program," said Peter Hwang, CEO of OSR Health. "Investors who enroll and hold will receive additional shares - and the value of those shares will be determined entirely by the market's assessment of what we are building, not by any mechanical "ex date" adjustment. The communication affirms that our loyalty program is additive, and gives shareholders clarity as they approach the August 14 record date."</p><p>Under the Shareholder Loyalty CVR program, shareholders of record as of the Record Date, August 14, 2026 who complete Enrollment are eligible to receive one CVR for each share of OSRH common stock held. Enrolled shareholders who hold their shares continuously are eligible to receive additional shares of common stock, at no cost, as defined closing-price thresholds are met at four measurement dates over the following twelve months. Details of the program, eligibility, and enrollment instructions for both U.S. and non-U.S. shareholders are available at <a rel="nofollow" href="https://pr.report/ogbg"><u>www.osr-health.com/loyaltyprogram</u></a></p><p>The reference to Nasdaq's position described above relates solely to the exchange's treatment of the CVR distribution and related share deliveries for price-adjustment purposes. It does not constitute an endorsement of the program or of an investment in OSRH, and it does not address the separate securities-law requirements applicable to the distribution of the CVRs and the delivery of shares, which remain subject to the Company's ongoing regulatory process as previously disclosed.</p><p>"Our priority now is making enrollment as clear and straightforward as possible, so that every eligible shareholder is positioned to reap the full benefit of this innovative program should its price milestones be reached," said Tim Smith, Head of Investor Relations at OSR Health. "We don't want a single shareholder who wishes to participate to miss out over a process step. We're here to help maximize participation for the shareholders who believe in what we're building."</p><p><strong>About OSR Health</strong><br/>OSR Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/OSRH">OSRH</a>) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Holdings engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at <a rel="nofollow" href="https://pr.report/ogbh"><u>www.osr-health.com</u></a></p><p><strong>Investor Contact</strong><br/>OSR Health, Inc.<br/>Investor Relations<br/><a rel="nofollow" href="mailto:ir@osr-health.com"><u>ir@osr-health.com</u></a></p><p><strong>Forward-Looking Statements</strong><br/>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Shareholder Loyalty CVR program, its treatment by Nasdaq, and the potential delivery of additional shares. These statements are subject to risks and uncertainties, including the satisfaction of the program's holding-period and price conditions, the outcome and timing of the Company's separate securities-law and regulatory processes, the Company's continued listing on Nasdaq, and other factors described in the Company's filings with the SEC. Actual results may differ materially. The Company undertakes no obligation to update any forward-looking statement except as required by law. This release does not constitute an offer to sell or a solicitation of an offer to buy any securities.</p><p><strong>SOURCE: </strong>OSR Health, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/biotechnology/osr-health-secures-nasdaq-communication-loyalty-cvr-program-will-not-trigger-a-price-1199591'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1199591" width="0" height="0"/>

OSRH

OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment

Nasdaq Confirms OSR Health CVR Adds Shares Without Price Adjustment

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>BELLEVUE, WA / ACCESS Newswire / July 31, 2026 / OSR Health, Inc. (NASDAQ:OSRH) (&amp;#34;OSR Health&amp;#34; or the &amp;#34;Company&amp;#34;) today announced that the Nasdaq Stock Market (&amp;#34;Nasdaq&amp;#34;) stated in a verbal</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>OSR Health disclosed Nasdaq confirmed there will be no mechanical price adjustment for its Shareholder Loyalty CVR program, making the plan additive. Eligible shareholders enrolled by August 14, 2026 can receive extra OSRH shares as price milestones are reached, with the value determined by the market. The outcome hinges on enrollment rates and milestone progress over the next 12 months.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Nasdaq said OSRH&#039;s Shareholder Loyalty CVR causes no price adjustment.</li><li>Enrolled holders will receive additional OSRH shares at no cost as milestones are met.</li><li>Record date is August 14, 2026; enrollment required to be eligible.</li><li>Value of added shares is market-determined; no ex-date or downward adjustment.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>OSR Health, Inc. (OSRH)</strong>: CVR program adds shares to eligible holders; market-determined value post-milestones.</li><li><strong>Nasdaq Stock Market (NDAQ)</strong>: Provided verbal guidance that CVR distributions won&#039;t trigger price adjustments; impact is structural, not endorsement.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. This is a structural financing/compensation mechanism (CVR) affecting OSRH&#039;s equity dynamics and investor participation, not an operating update or earnings event. It fits as a corporate action with potential near-term price sensitivity around the record date and enrollment.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Record date set for August 14, 2026, potentially driving near-term activity around enrollment.</li><li>No mechanical price adjustment reduces downside risk from CVR mechanics.</li><li>Added shares are earned via market-determined milestones, creating optionality.</li><li>Progress on enrollment and milestone thresholds will be key price drivers.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Record Date: August 14, 2026.</li><li>CVR terms: one CVR per share enrolled; additional shares at four closing-price milestones over 12 months.</li><li>Nasdaq indicated no ex-date or downward price adjustment for CVR distribution/delivery.</li><li>Enrollment details: www.osr-health.com/loyaltyprogram.</li><li>Forward-looking statements subject to regulatory processes and other risks.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bullish over the next 6–12 months if enrollment drives meaningful added equity; upside depends on milestone achievement and market valuation.</p>
  </section>
</section>


<p><strong id="dateline">BELLEVUE, WA / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / July 31, 2026 / </strong>OSR Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/OSRH">OSRH</a>) ("OSR Health" or the "Company") today announced that the Nasdaq Stock Market ("Nasdaq") stated in a verbal communication with the Company that the Company's Shareholder Loyalty Contingent Value Rights (CVR) program will not result in any mechanical adjustment to the price of OSR Health's common stock - either upon the distribution of the CVRs or upon the delivery of additional shares of common stock to enrolled holders under the program.</p><p><strong>What this means for shareholders:</strong></p><ul style="list-style-type:disc;"><li><p><strong>No mechanical price adjustment.</strong> Nasdaq will not apply an ex-date or other downward adjustment to the OSRH share price in connection with the CVR distribution or the delivery of additional shares.</p></li><li><p><strong>Purely additive.</strong> Enrolled holders receive additional shares at no cost as the program's price milestones are met.</p></li><li><p><strong>Market-determined value.</strong> The value of OSRH shares will be set by the market - not adjusted by the exchange.</p></li><li><p><strong>Record date: August 14, 2026.</strong> Hold your shares by this date to be eligible.</p></li></ul><p>"This communication with Nasdaq provides clarity on an important structural question about our CVR Program," said Peter Hwang, CEO of OSR Health. "Investors who enroll and hold will receive additional shares - and the value of those shares will be determined entirely by the market's assessment of what we are building, not by any mechanical "ex date" adjustment. The communication affirms that our loyalty program is additive, and gives shareholders clarity as they approach the August 14 record date."</p><p>Under the Shareholder Loyalty CVR program, shareholders of record as of the Record Date, August 14, 2026 who complete Enrollment are eligible to receive one CVR for each share of OSRH common stock held. Enrolled shareholders who hold their shares continuously are eligible to receive additional shares of common stock, at no cost, as defined closing-price thresholds are met at four measurement dates over the following twelve months. Details of the program, eligibility, and enrollment instructions for both U.S. and non-U.S. shareholders are available at <a rel="nofollow" href="https://pr.report/ogbg"><u>www.osr-health.com/loyaltyprogram</u></a></p><p>The reference to Nasdaq's position described above relates solely to the exchange's treatment of the CVR distribution and related share deliveries for price-adjustment purposes. It does not constitute an endorsement of the program or of an investment in OSRH, and it does not address the separate securities-law requirements applicable to the distribution of the CVRs and the delivery of shares, which remain subject to the Company's ongoing regulatory process as previously disclosed.</p><p>"Our priority now is making enrollment as clear and straightforward as possible, so that every eligible shareholder is positioned to reap the full benefit of this innovative program should its price milestones be reached," said Tim Smith, Head of Investor Relations at OSR Health. "We don't want a single shareholder who wishes to participate to miss out over a process step. We're here to help maximize participation for the shareholders who believe in what we're building."</p><p><strong>About OSR Health</strong><br/>OSR Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/OSRH">OSRH</a>) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Holdings engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at <a rel="nofollow" href="https://pr.report/ogbh"><u>www.osr-health.com</u></a></p><p><strong>Investor Contact</strong><br/>OSR Health, Inc.<br/>Investor Relations<br/><a rel="nofollow" href="mailto:ir@osr-health.com"><u>ir@osr-health.com</u></a></p><p><strong>Forward-Looking Statements</strong><br/>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Shareholder Loyalty CVR program, its treatment by Nasdaq, and the potential delivery of additional shares. These statements are subject to risks and uncertainties, including the satisfaction of the program's holding-period and price conditions, the outcome and timing of the Company's separate securities-law and regulatory processes, the Company's continued listing on Nasdaq, and other factors described in the Company's filings with the SEC. Actual results may differ materially. The Company undertakes no obligation to update any forward-looking statement except as required by law. This release does not constitute an offer to sell or a solicitation of an offer to buy any securities.</p><p><strong>SOURCE: </strong>OSR Health, Inc.</p><br/><br/>View the original <a href='https://www.accessnewswire.com/newsroom/en/biotechnology/osr-health-secures-nasdaq-communication-loyalty-cvr-program-will-not-trigger-a-price-1199591'>press release</a> on ACCESS Newswire<br/><br/>
      <img src="https://app.accessnewswire.com/img.ashx?id=1199591" width="0" height="0"/>

OSR Health disclosed Nasdaq confirmed there will be no mechanical price adjustment for its Shareholder Loyalty CVR program, making the plan additive. Eligible shareholders enrolled by August 14, 2026 can receive extra OSRH shares as price milestones are reached, with the value determined by the market. The outcome hinges on enrollment rates and milestone progress over the next 12 months.

News insight

OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment

AI summary

Sentiment rationale

Key facts

Corporate Developments